Head-to-head dispatch
Harbor vs Jyra Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market.
Marked down on: Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
Desk Score
Jyra Health is an online weight-loss and longevity telehealth clinic offering compounded GLP-1 — semaglutide from $99/mo and tirzepatide from $133/mo (limited time) — prescribed by board-certified providers…
Marked down on: The $133/mo tirzepatide price is flagged 'limited time' — verify current pricing before enrolling
Jyra Health takes this head-to-head with the higher Desk Score, 75/100 (C) against 65/100 (C) for Harbor. Harbor still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Harbor
65/100
C
Jyra Health
75/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Harbor | Jyra Health |
|---|---|---|
| Semaglutide | $99/mo (starting dose, compounded) | $99/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | $149/mo (starting dose, compounded) | $133/mo (starting dose, promotional rate, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Readers who want adults seeking the lowest-cost compounded GLP-1 with physician oversight and a 12-month money-back guarantee. | Readers who want budget shoppers wanting very low-cost compounded semaglutide or tirzepatide in any state. |
| Desk Score | 65/100C | 75/100C |
The verdict
Desk pick — Jyra HealthJyra Health takes this head-to-head with the higher Desk Score, 75/100 (C) against 65/100 (C) for Harbor. Harbor still holds its ground where its strengths line up with yours.
Choose Harbor if…
Readers who want adults seeking the lowest-cost compounded GLP-1 with physician oversight and a 12-month money-back guarantee.
$99/mo (starting dose, compounded) sema · $149/mo (starting dose, compounded) tirz · Coverage not published
Choose Jyra Health if…
Readers who want budget shoppers wanting very low-cost compounded semaglutide or tirzepatide in any state.
$99/mo (starting dose, plus a separate fee, compounded) sema · $133/mo (starting dose, promotional rate, compounded) tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Harbor · Jyra Health.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Harbor vs CoreAge Rx
- Jyra Health vs Vaylen
- Harbor vs Strut Health
- Jyra Health vs Ondra Health
- Harbor vs Invigor Medical
- Jyra Health vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.